Relevance of an Adapted and Supervised Physical Activity Program in Fibromyalgia Patients. The FIMOUV 1 Study. (FIMOUV 1)
Relevance of an Adapted and Supervised Physical Activity Program in Fibromyalgia Patients. The FIMOUV 1 Study. Interventional, Controlled, Randomized, Open Study of an Original Outpatient Management.
Fibromyalgia affects 2 to 5% of adults in the general population. Patients describe a combination of symptoms centred around fatigue not induced by exercise and not relieved by rest.
The diagnosis of fibromyalgia is self-perpetuating by the deconditioning, consequence of a reduced muscle mass due to inactivity and periods of prolonged rest.
Thus, it seems fundamental to develop other non-drug approaches: among them, adapted physical activity is recommended by most learned societies because of a good level of evidence (Level 1, Grade A). The question remains, however, whether simple advice to resume physical activity is sufficient (routine care with medical assessment at 3 months) or whether a physical activity supervised inside and outside the hospital is not more relevant.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
Saint Etienne, Frankrike, 42055
- CHU Saint Etienne
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Patient lived in t Loire (42) or Haute-Loire (43)
- Patient diagnosed with fibromyalgia according to ACR (American College of rheumatology) criteria (total score WPI (Widespread Pain Index) + SS (Severity Scale) ) ≥ 13
- French writing and speaking
- Sedentary or low level of activity (less than 2 hours of regular physical activity per week at the time of inclusion)
- Signature of informed consent
Exclusion Criteria:
- Cardiac or respiratory diseases that contraindicate the practice of physical activity
- Significant co-morbidities that contraindicate the practice of physical activity: associated cardiac pathologies (severe rhythm disorders such as rapid atrial fibrillation), respiratory pathologies (severe obstructive or severe respiratory insufficiency), disabling joint pathologies (knee osteoarthritis or osteoarthritis of the hip) training on a treadmill or on a high intensity bike).
- Impossibility of submitting to the medical monitoring of the program for geographical, social or psychological reason
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Övrig
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: fibromyalgipatienter med fysiskt aktivitetsprogram
Två träningspass i veckan på universitetssjukhuset i St-Etienne under 1 månad och sedan stafett utomhus i en idrottsförening eller klubb certifierad "Sports Health" i Loire (42) eller Haute-Loire (43) i 2 månader.
|
Two weekly exercise sessions at the university hospital of St-Etienne for 1 month then relay outside in a sports association or club certified "Sports Health" in the Loire (42) or Haute-Loire (43) for 2 months.
|
|
Övrig: fibromyalgipatienter med fysisk aktivitet hemma
Råd och rekommendationer om fysisk aktivitet i hemmet (= aktuell klinisk praxis, från 1 till 3 sessioner per vecka i autonomi).
|
Råd och rekommendationer om fysisk aktivitet i hemmet (= aktuell klinisk praxis, från 1 till 3 sessioner per vecka i autonomi).
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Assessment of the impact of a 3-month program
Tidsram: at 3 months
|
Health status assessed by the PGIC = Patient Global Impression of Change.
interpretation : 0= no change, 7= clear improvement, 5= better).
|
at 3 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
fatigue
Tidsram: at 3 months
|
assessed by Fatigue Severity Scale. This is a short questionnaire of 9 questions to which the patient answers on a scale from 1 to 7. Simply add the scores and divide by 9 - you get a result on 7 points. The higher the result, the greater the fatigue. Several studies speak of a threshold at 5.5 |
at 3 months
|
|
Quality of sleep
Tidsram: at 3 months
|
assessed by the Pittsburgh. The questionnaire includes 19 self-assessment questions and 5 questions for the spouse or roommate (if any). Only self-assessment questions are included in the score. The 19 self-assessment questions combine to give 7 components" of the score with each component receiving a score of 0 to 3. In all cases, a score of 0 indicates that there is no difficulty while a score of 3 indicates the existence of severe difficulties. The 7 components of the score add up to give an overall score from 0 to 21 points, 0 meaning that there is no difficulty, and 21 indicating on the contrary major difficulties. |
at 3 months
|
|
Anxiety and Depression
Tidsram: at 3 months
|
assessed by the Hospital Anxiety and Depression Scale (HADS) : An overall score of 19 or more indicates a major depressive episode.
An overall score of 13 corresponds to adjustment disorders and minor depression.
|
at 3 months
|
|
pain catastrophizing
Tidsram: at 3 months
|
assessed by the PCS (pain catastrophizing scale) assessing catastrophism : there are thirteen statements describing different thoughts and emotions that may be associated with pain. the person must indicate how painful these thoughts and emotions are.
From 0= not at all to 4 = all the time
|
at 3 months
|
|
pain evaluation
Tidsram: at 3 months
|
assessed by analog visual evaluation of pain (0= no pain and 10 = very painful)
|
at 3 months
|
|
muscle power
Tidsram: at 3 months
|
evaluated by dynamometry on a stress platform (arms and legs) and by a pocket dynamometer.
|
at 3 months
|
|
muscular endurance
Tidsram: at 3 months
|
evaluated by dynamometry on a stress platform (arms and legs).
|
at 3 months
|
|
gas exchange measurement
Tidsram: at 3 months
|
evaluated during a stress test
|
at 3 months
|
|
quantification of physical activity in meter-h/week
Tidsram: at 3 months
|
evaluated by the APAQ : Adult Physical Activity Questionnaire
|
at 3 months
|
|
sedentary times in hours/day
Tidsram: at 3 months
|
evaluated by the APAQ : Adult Physical Activity Questionnaire
|
at 3 months
|
|
daily energy expenditure
Tidsram: at 3 months
|
evaluated by actimetry
|
at 3 months
|
|
time of physical activity
Tidsram: at 3 months
|
evaluated by actimetry
|
at 3 months
|
|
physical inactivity
Tidsram: at 3 months
|
evaluated by actimetry
|
at 3 months
|
|
patient adherence
Tidsram: at 3, 6 and 12 months
|
number of sessions performed
|
at 3, 6 and 12 months
|
|
Direct medical costs
Tidsram: at 3, 6 and 12 months
|
consultations, examinations, hospitalizations in euros
|
at 3, 6 and 12 months
|
|
Direct non-medical costs
Tidsram: at 3, 6 and 12 months
|
transport
|
at 3, 6 and 12 months
|
|
Cost of lost productivity
Tidsram: at 3, 6 and 12 months
|
time not worked
|
at 3, 6 and 12 months
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: David HUPIN, MD, CHU de Saint Etienne
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 18CH051
- 2018-A01597-48 (Annan identifierare: ANSM)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .